Showing 15 posts of 16 posts found.

Shionogi’s Mulpleo recommended for NHS use across England, Wales and Scotland for chronic liver disease

December 12, 2019
Sales and Marketing England, Mulpleo, NICE, Scotland, Scottish Medicines Consortium, Shionogi, Wales

Both the regulators governing NHS use of medicines in England, Wales and Scotland – the National Institute for Health and …


Public satisfaction with NHS falls to lowest point since 2007

March 7, 2019
Medical Communications England, King's, NHS, Nuffield, Scotland, UK, Wales, kings, public stisfaction

Public satisfaction with the NHS has fallen to lowest levels since 2007, according to analysis of the 2018 British Social …

More children suffering from type 2 diabetes in England and Wales

August 20, 2018
Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people

The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …

NICE recommends Eli Lilly’s psoriatic arthritis drug

August 9, 2018
Research and Development, Sales and Marketing Eli Lilly, England, NICE, Wales, psoriatic arthritis

Eli Lilly have announced that the monoclonal antibody ixekizumab, has been recommended by NICE for use as a treatment option …


Essentra packaging facility co-funded by Welsh Government to close

July 27, 2017
Manufacturing and Production Essentra, Wales, Welsh Government, biotech, drugs, packaging, pharma, pharmaceutical

Essentra, a manufacturer of packaging for the pharmaceutical and retail industry, has revealed that it is undergoing a consultation process …


Welsh government launches £80 million fund for newly approved drugs

January 13, 2017
Medical Communications Wales, Welsh Government, drug fund

The Welsh Government has created a five-year £80 million drug fund, which will work out to an additional £16 million …


Wales approve pancreatic cancer drug for use despite NICE rejection in England

March 18, 2016
Medical Communications, Research and Development Abraxane, Celgene, England, NHS, NICE, Wales, approval

Celgene (Nasdaq: CELG) has announced that Abraxane, in combination with gemcitabine, will continue to be an available treatment option for …

Norgine logo

Norgine opens new £4.5 million warehouse

November 17, 2015
Manufacturing and Production, Research and Development Norgine, Temperature control, Wales, manufacturing, production, temperature-control

Norgine has opened a new £4.5 million temperature controlled warehouse on its current site in Hengoed, Wales.  The Dutch-based firm …

Welsh Assembly image

Wales Assembly facing questions over cancer

November 5, 2014
Research and Development, Sales and Marketing CDF, Cancer, NHS, Wales, Welsh, assembly, drugs fund, oncology

The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …


Life Sciences Hub Wales – new COO and

June 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Hub Wales, Wales, ian barwick

Dr Ian Barwick has been appointed chief operating officer for Life Sciences Hub Wales along with several new board members.

penn pharma image

Penn Pharma starts operations

June 9, 2014
Manufacturing and Production, Sales and Marketing API, Penn Pharma, Wales, manufacturing, south

Penn Pharma has opened its expanded facility in South Wales, after a £3 million investment which will allow it to …

NICE image

‘Inequality’ for Welsh cancer patients

August 28, 2013
Sales and Marketing CDF, Cancer, England, NHS, NICE, Wales

Cancer sufferers in England are four times more likely to receive newer treatments on the NHS than patients in Wales, …

ReNeuron relocates to Wales

July 22, 2013
Research and Development, Sales and Marketing ReNeuron, Wales, stem cell, stroke

The Welsh government is to fork out a £7.8 million grant package to get English stem cell research company ReNeuron …

Cancer Drugs Fund ‘the wrong choice’ for Wales

May 29, 2012
Sales and Marketing CDF, Cancer, NHS, Wales, Welsh

The Welsh health minister Lesley Griffiths has said that a Cancer Drugs Fund is ‘not the right course’ for Wales. …

Zytiga image

Zytiga approved in Wales – for now

February 21, 2012
Sales and Marketing AWMSG, CDF, Janssen, NICE, Wales, Zytiga

Janssen’s cancer treatment Zytiga has been approved in Wales, in contrast to its rejection by NICE. The All Wales Medicines …

Latest content